Hybrid models are a perfect fit for the conditions encountered in bioprocess development. Their impact on bioprocess operations is both broad and significant.
The use of Hybrid models in bioprocess development can be dramatic. The model's ability to generate qualitative insights with limited data translates into significant operational benefits - find out how.
As innovation floods the Biopharma industry, innovation leads have more choices than ever. This fortunate problem creates a new challenge - how to select the best approach?